1 Division of Mammalian Development,
2 Division of Protein Structure, National Institute for Medical Research, The Ridgeway, London NW7 1AA, UK
3 Institute of Child Health, 30 Guilford Street, London WC1N 1EH, UK
4 Department of Paediatric Endocrinology, John Radcliffe Hospital, Headley Way, Headington, Oxford OX3 9DU, UK
* Present address: Centre for Genome Research, The University of Edinburgh, Kings Buildings, West Mains Road, Edinburgh EH9 3JQ, UK
Authors for correspondence (e-mail: Josh.Brickman{at}ed.ac.uk and M.Dattani{at}ich.ucl.ac.uk)
Accepted October 10, 2001
![]() |
SUMMARY |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Key words: Repression, Homeodomain, Pituitary, Hesx1/HESX1, Transcription
![]() |
INTRODUCTION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The Paired (prd) class of homeodomain proteins binds to DNA cooperatively as dimers (Wilson et al., 1993). Some members of this family are characterised by the possession of an additional DNA-binding domain (the Prd domain), e.g. Drosophila prd and the Pax genes, while other members of this family contain only a prd class homeodomain, e.g. Hesx1, Goosecoid (Gsc). The prd homeodomain is known to bind cooperatively to adjacent TAAT cores and the spacing between cores preferred by specific prd domain proteins also depends on the ninth residue of helix three of the homeodomain.
The prd homeodomain protein HESX1 (also know as Rpx) was recently implicated in the human disease Septo-Optic Dysplasia (SOD) (Dattani et al., 1998). Hesx1 is expressed early in mouse development, beginning with a small patch of cells in the anterior midline visceral endoderm (Hermesz et al., 1996; Thomas and Beddington, 1996). Expression later continues in the prospective forebrain and is then restricted to Rathkes pouch, the primordium of the anterior pituitary. Mice homozygous for a null mutation in the Hesx1 locus display variable defects in the anterior CNS such as micro- or anophthalmia, and agenesis of midline forebrain derivatives, including the corpus callosum and septum pellucidum. They also exhibit pituitary dysplasia. The phenotype of the Hesx1 null mice is similar to human SOD, which consists of congenital panhypopituitarism, optic nerve hypoplasia and/or abnormalities of midline brain structures. A familial form of SOD has recently been described in association with a homozygous mutation in the HESX1 locus (Dattani et al., 1998).
Two observations suggest that Hesx1 functions as a transcriptional repressor in vivo. First, Hesx1 interacts with the co-repressor NcoR1 and can repress the tk promoter through an NcoR1-dependent mechanism (Xu et al., 1998). Second, Hesx1 also contains an amino acid sequence known as the engrailed homology domain 1 (eh-1) (Smith and Jaynes, 1996). Eh-1 is characterised by a conserved seven amino acid sequence, which is present in a large number of homeodomain proteins (Smith and Jaynes, 1996). In Engrailed, eh-1 is required for both repression in vivo in Drosophila (Smith and Jaynes, 1996) and for repression by Engrailed from integrated reporters in cell culture (Tolkunova et al., 1998).
While mechanisms of transcriptional repression are less well understood than those of activation, several themes have become apparent. Like activators, repressors have modular domains that can function independently of DNA binding to repress transcription. Repressors are believed to act by one of three potential modes: competition with activators for the same binding sites ("passive repression"), a direct inhibitory effect on the transcriptional machinery ("direct repression") or by interacting with a DNA-bound activator to abrogate its activity ("quenching") [reviewed by Hanna-Rose and Hansen, and Levine and Manley (Hanna-Rose and Hansen, 1996; Levine and Manley, 1989)].
We have investigated the molecular basis for a variety of clinical phenotypes that arise as a consequence of mutations in HESX1. As we have worked with both the mouse and human proteins, we will refer to them according to the species-specific nomenclature, Hesx1 (mouse) and HESX1 (human) (Hesx1 will be used for all generalisations). We have screened a large number of patients with pituitary defects and here describe an association between HESX1 mutations and the magnetic resonance imaging (MRI) scan findings of an undescended or ectopic posterior pituitary gland. In contrast to the classical SOD phenotype observed with the autosomal recessive HESX1 (R160C) mutation we show milder phenotypes in association with the heterozygous HESX1 (S170L) mutation. At a molecular level we show that Hesx1 can bind with high affinity to either dimer or monomer homeodomain DNA sites and that it acts as a transcriptional repressor in transient transfection experiments. Mutations linked to pituitary phenotypes affect DNA binding and not transcriptional repression. However, HESX1(R160C) has a dominant negative activity both in vitro and in vivo and this dominant negative activity requires the repression domain that we have mapped to 36 amino acids containing eh-1 outside of the homeodomain. We also show that the repression domain in Hesx1 can suppress the activity of a homeodomain based activator of the Prd class. The involvement of the Hesx1 repression domain in mediating functional interactions with partner proteins suggests a possible mechanism whereby mutations in other domains of Hesx1 may lead to dominant pituitary phenotypes.
![]() |
MATERIALS AND METHODS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Cell culture and transfections
Feeder-independent ES cells were maintained in gelatinised flasks in Dulbeccos modified Eagles medium (DMEM) supplemented with 20% fetal calf serum and leukaemia inhibiting factor (Smith et al., 1988). ES cell lines were E14.2 (Fisher et al., 1989) and CGR8 (Mountford et al., 1994). Transient transfections were performed as described previously (Brickman et al., 2000). COS-7 cells were cultured in DMEM containing sodium pyruvate supplemented with 10% fetal calf serum. Western blots on transfected COS cells were performed by transfecting 1.2 µg of the indicated expression vector into a 1.0 cm dish by lipofection using Lipofectamine (Gibco BRL) according to the instructions of the manufacturer. Extracts were made in RIPA with gentle agitation at 4°C for 30 minutes. Lysates were clarified and diluted with 2x Laemmli sample buffer. Blots were probed with -VP16 antibody (Santa Cruz) at a concentration of 200 ng/ml and an
-mouse horseradish peroxidase antibody (Sigma) at a concentration of 100 ng/ml. They were visualised by chemiluminescence using an ECL kit (Amersham) according to the instructions of the manufacturer.
Purification of recombinant proteins
All HESX1 proteins were expressed and purified as previously described using derivatives of the plasmid pJBE21, which contains ten histidine residues upstream of an amino-terminal poly-linker (Dattani et al., 1998). Briefly, insoluble material from lysates of Escherichia coli strain BL21/(DE3) was solubilised in 20 mM Tris pH 8.0, 100 mM KCl, 20% (w/v) glycerol, 6 M urea, 1 mM phenylmethylsulfonyl fluoride and 1 mM imidazole and fractionated by nickel (Ni2+) affinity chromatography. HESX1-containing fractions were eluted in a stepwise manner using increasing concentrations of imidazole. The proteins were then renatured by dialysis against 50 mM Tris pH 8.0, 600 mM NaCl, 10 mM MgCl2, 20% (v/v) glycerol, 0.1% Nonidet P40, 10 mM dithiothreitol and 1 mM phenylmethylsulfonylfluoride containing decreasing amounts of urea. Electrophoretic mobility shift assays (EMSA) were performed as previously described (Brickman et al., 1999). The oligonucleotides used in the EMSA assays were 5'AGCTTGAGTCTAATTGAATTACTGTAC3' for the P3 site and 5'TCGAGCAATTAAATTCCCAGGATTATC3' and 5'GATCATGATAATCCTGGGAATTTAAGCA3' for the monomeric site in the Gsc promoter. Anti-His antibody was pre-incubated with gel shift reactions as in Fig. 2C at a concentration of 12.0 ng/µl.
|
Patient recruitment and mutational screening
A total of 461 patients (163 with classical septo-optic dysplasia, 223 with variable pituitary hormone deficiencies, 9 with optic nerve hypoplasia, 3 with midline neuroradiological abnormalities and 63 with a variety of midline disorders such as holoprosencephaly) were recruited from Great Ormond Street Hospital for Sick Children (GOSH), University College London Hospitals (UCLH) and a variety of other sources. The majority of cases were sporadic apart from the two pedigrees described below and eight other families with variable degrees of SOD and Combined Pituitary Hormone Deficiency (CPHD). Ethical Committee approval for the study was obtained at both GOSH and UCLH. Mutation screening was performed using PCR followed by single-stranded conformational polymorphism (SSCP) as described previously (Dattani et al., 1999; Thomas et al., 2001). Samples showing any band shifts on SSCP analysis were then sequenced. We originally described a homozygous mis-sense mutation C478T (R160C substitution) in two siblings with SOD from a highly consanguineous pedigree (Dattani et al., 1999). More recently, we have described three non-conservative mis-sense heterozygous mutations, namely C509T in pedigree 2 (S170L substitution), A541G (T181A substitution) and G18C (Q6H) (Thomas et al., 2001). The C509T and A541G mutations were not found in 140 control chromosomes, and the G18C mutation was not observed in 100 control chromosomes. The inheritance pattern was autosomal dominant with variable penetrance. Additionally, we have documented a heterozygous A374G (N125S) change in 5 children of Afro-Caribbean descent, all of whom have variable SOD phenotypes. We have identified this as a probable polymorphism in the Afro-Caribbean population (see below).
![]() |
RESULTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
|
A third patient with the S170L substitution has recently been identified. The patient presented at the age of 6 years with short stature, having grown with a sub-optimal height velocity since the age of 2 years. His birth weight was 3.5 kg and the delivery was unremarkable. On presentation, the patient had a height well below the 0.4th height centile (99.7 cm at 6.4 years). His vision was reported as being normal and fundoscopy revealed no abnormal findings. An insulin tolerance test combined with a TRH test was performed to assess his pituitary function, and revealed a peak GH response to hypoglycaemia of 1.1 mU/l (0.4 ng/ml), confirming a diagnosis of severe GH deficiency. His cortisol secretion was normal (peak cortisol 772 nmol/l) as were his TSH (peak 8.2 mU/l) and prolactin (peak 799 mU/l) responses to TRH. He was treated with recombinant hGH until the age of 15 years, by which time he had achieved a height of 169.7 cm, which placed him between the 9th and 25th centiles (mid-parental centile 25th). He progressed through puberty normally. His hypothalamo-pituitary axis was re-tested following cessation of the GH treatment and he achieved a peak GH response of 0.9 mU/l (0.36 ng/ml) on re-testing, with normal thyroid function and cortisol concentrations. Magnetic resonance imaging of his brain and pituitary gland revealed an atrophic posterior lobe of the pituitary gland that had not descended into the pituitary fossa. The pituitary stalk was very thin with a poorly enhancing anterior pituitary (Fig. 1D). No other midline structural defects were identified. In spite of the abnormal appearance of the posterior pituitary gland, this patient did not manifest diabetes insipidus.
The heterozygous S170L mutation was clearly associated with highly variable phenotypes in terms of the presence of optic nerve hypoplasia and MRI scan appearances. However, it is noteworthy that all of the affected individuals demonstrated a defect in GH secretion with no other pituitary hormone deficit, suggesting that somatotropes may be particularly vulnerable to perturbations in HESX1.
N125S
Five of our 461 patients were heterozygous for the N125S substitution in HESX1. All of these patients were of an Afro-Caribbean background. This substitution is probably a frequent polymorphic variant within this particular ethnic group. Screening an unaffected Afro-Caribbean population for this polymorphism revealed 5 homozygotes for the wild-type allele, 17 homozygotes for the N125S substitution and 20 heterozygotes for the substitution. However, this mutation may not be entirely silent since the substitution of a serine residue by proline at the analogous position 18 in the homeodomain of Prop1 has previously been implicated in the phenotype of the Ames dwarf mouse (Sornson et al., 1996).
DNA-binding properties of Hesx1/HESX1 and HESX1 mutants
We have previously shown that the R160C substitution in HESX1 resulted in a loss of DNA binding, even at micromolar concentrations, as compared with the wild-type protein which had a high DNA-binding affinity for the consensus P3 DNA sequence (Wilson et al., 1993), a synthetic palindrome shown to bind prd homeodomain proteins (Table 1). To further examine the molecular consequences of point mutations associated with both heritable and sporadic forms of SOD, we over-expressed and purified from bacteria wild-type HESX1, HESX1(S170L), HESX1(R160C) and HESX1(N125S). Fig. 2 shows the binding of the HESX1(S170L) and HESX1(N125S) proteins to two classes of homeodomain site, the dimeric P3 site and a naturally occurring site, known as GBS, from the Brachyury promoter, which is thought to bind paired class homeodomains as monomers (Latinkic and Smith, 1999). Table 1 shows the dissociation constants for the binding of the various proteins to these two sites. Fig. 2C shows a ternary complex formed by HESX1 and an antibody to the amino-terminal histidine (His) tag. The presence of this antibody appears to stabilize the DNA-protein complex formed by both the wild-type HESX1 and HESX1(S170L).
|
HESX1/Hesx1 is a transcriptional repressor and contains a 36 amino acid repression domain
In order to further characterise mutations in HESX1 associated with SOD we extended our functional studies from DNA binding in vitro to transcriptional regulation and DNA binding in vivo as assayed by transient transfection assays. Fig. 3A shows that Hesx1 is a transcriptional repressor when fused to the DNA-binding domain of GAL4. DNA encoding GAL4-Hesx1 was co-transfected into ES cells together with a reporter containing GAL4 DNA-binding sites upstream of the SV40 promoter. Identical results were obtained in COS cells (data not shown). Fig. 3A shows that the repression activity mapped to 36 amino acids (aas) at the amino terminus of Hesx1 in a region that is highly conserved across species boundaries. Deletion or removal of this region from Hesx1 resulted in a dramatic reduction in repression by GAL4-Hesx1, but had no noticeable effect on the levels of Hesx1 expressed in transfected COS cells as determined by western blot analysis (Fig. 4). This region contains a stretch of seven amino acids, FSIESIL, previously implicated in transcriptional repression by Engrailed and Goosecoid, the eh-1 or Engrailed homology domain. A point mutation in eh-1 resulting in the substitution of the conserved Phe by Glu significantly compromises its activity (Smith and Jaynes, 1996; Tolkunova et al., 1998). Fig. 3A shows that mutation of the analogous position in Hesx1, Hesx1F21A, resulted in a loss of repression activity by GAL4-Hesx1.
|
|
Fig. 3D shows that a completely different result was obtained when these GAL4 fusion proteins were assayed from the minimal Adenovirus E4 promoter element. When a minimal 49 amino acid Hesx1 peptide fused to GAL4 was assayed off this promoter, it had no effect on transcription, wherease the same fragment repressed SV40 transcription 6-fold. Repression by HESX1 therefore appears to be a promoter-specific phenomenon, and presumably involves interaction with partner proteins since the SV40 promoters contains several consensus homeodomain sites while the E4 promoter does not.
We therefore tested the ability of Hesx1 to repress transcription from the minimal Adenovirus E4 promoter containing an upstream P3 site when it was activated by a homeodomain-containing activator. Co-transfection of DNA encoding full-length Hesx1, together with expression vectors for paired class activators of the Mix family (Germain et al., 2000), Bix (Tada et al., 1998), Mix-1 (Mead et al., 1996) and Mixer (Henry and Melton, 1998) led to a dramatic repression of these transcriptional activators (Fig. 5A). Hesx1 was able to repress transcription activated by Bix 91-fold. However, when DNA encoding Bix was co-transfected with a plasmid expressing a Hesx1 deletion derivative lacking the repression domain, Hesx1(50-185), Bix-mediated activation was repressed by only up to 4.2-fold, even when DNA encoding Hesx1(50-185) was present in equimolar amounts to that encoding the Bix activator (Fig. 5B). When DNA expressing full-length Hesx1 was present at 10-fold lower levels than those of the vector expressing the Bix activator, activation by Bix was still significantly repressed (greater than 10-fold) whereas DNA expressing Hesx1(50-185) had no significant effect on Bix activity at these levels (Fig. 5B). Since the quantity of Hesx1 required for these effects appears well below that required to saturate for DNA binding, we refer to this as cooperative repression.
|
|
|
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The eh-1-containing domain from Hesx1 repressed transcription from the SV40 promoter, or transcriptional activation stimulated by prd homeodomain-containing activators, but not from the minimal Adenovirus E4 promoter. Mutations in HESX1 associated with SOD affect DNA binding, rather than transcriptional repression. One of these mutations, HESX1(R160C), has a dominant negative effect on HESX1, both in vivo and in vitro. This activity is dependent on the eh-1-containing N-terminal repression domain.
Promoter-specific/cooperative repression by Hesx1
Hesx1-mediated repression does not affect the minimal Adenovirus E4 promoter, which contains a consensus TATA box and initiator but no additional regulatory sequences (Lin et al., 1988). Hesx1 is therefore unable to mediate repression through a direct interaction with the basal transcription complex bound at the E4 promoter. However, when Prd class homeodomain-binding sites are placed upstream of the E4 promoter and a prd class homeodomain activator is added, Hesx1 can now repress transcription stimulated by the homedomain activator. There are two possible mechanisms by which this might occur: direct competition between the two homeodomain proteins for the P3 DNA site, or direct inhibition by Hesx1 of the activity of the homeodomain-containing activator through a physical interaction. Direct competition would not explain the magnitude of repression (up to 100-fold) observed in these experiments unless there were major differences in DNA binding affinity. However, the activities of Bix and Hesx1-VP4 over a range of concentrations suggest similar DNA binding affinities for the P3 site. Assuming that these proteins do have similar DNA binding affinities, direct competition could explain the magnitude of repression observed by Hesx1(50-185) (4-fold) when Hesx1(50-185) and Bix are present at a 1:1 ratio. Hesx1 can also repress transcription when it is present at 10-fold lower levels than the Mix family activator protein suggesting that formation of a heteromeric complex with the Mix family protein on DNA is cooperative and that repression occurs via an active quenching mechanism.
The ability of Gal4-Hesx1 fusions to repress the SV40 promoter is probably due to the presence of homeodomain activators. In addition to the multiple Sp1 sites and AT rich sequences immediately adjacent to the transcription start site [reviewed by McKnight and Tjian (McKnight and Tjian, 1986)], the SV40 promoter contains two perfect consensus sites for binding homeodomain proteins of the Caudal-like and Deformed families.
Several recent studies have implicated the eh-1 sequence within engrailed (Jimenez et al., 1997; Tolkunova et al., 1998), UNC-4 (Winnier et al., 1999), and Gsc (Jimenez et al., 1999) in the recruitment of the co-repressor Groucho. General recruitment of a global co-repressor such as Groucho would imply a more direct mechanism for transcriptional repression by eh-1 and suppression of basal transcription. However, the implication of our data is that eh-1 in Hesx1 mediates an interaction with other homeodomain-containing proteins to form a complex that can serve as a promoter-specific binding surface for Groucho. The interaction between a homeodomain or DNA binding motif with a repression domain may be a general feature of co-repressor recruitment. For example, Dorsal, which functions as both an activator and a repressor, interacts with co-factors that modulate both its promoter-specific regulatory activity (Brickman et al., 1999) and its capacity to recruit Groucho (Dubnicoff et al., 1997; Valentine et al., 1998) via its conserved DNA binding motif, the Rel domain.
Repression and dimerisation
The repression domain of Hesx1 is required for the dominant negative activity of HESX1(R160C). These findings are consistent with two observations with respect to Gsc eh-1; Gsc eh-1 mediates its physical interaction with the homeodomain of Otd and heteromeric repression by Gsc eh-1 is disrupted by mutations in the Otd homeodomain that interfere with dimerisation (Mailhos et al., 1998). In contrast to the isolated prd homeodomain, thought to be a monomer in solution (Wilson et al., 1993), our experiments with the HESX1(R160C) in vivo and in vitro suggest that full-length Hesx1 forms dimers in solution, and that this is dependent upon eh-1. The requirement of eh-1 for dimerisation and repression would be consistent with a model in which eh-1 interacts with homeodomain containing proteins to form a complex that can then recruit co-repressors such as Groucho.
This is one of the first reports of binding constants for intact recombinant proteins. We have determined the Kds for the binding of all proteins to both monomeric and dimeric sites. Our binding studies on the dimeric P3 site show a significant change in the dissociation constant, suggesting that the difference in Kd (6-fold) between the monomeric and dimeric sites was based upon the affinity of a dimer formed in solution for the P3 target sequence.
Implications for clinical phenotypes associated with HESX1 mutations
Our studies have suggested a rare role for HESX1 in milder pituitary phenotypes. It is noteworthy that all of our patients who have been documented as having mutations in HESX1 have impaired GH secretion with clinical evidence of GH deficiency. Additionally, HESX1 is the only gene to date associated with an ectopic/undescended posterior pituitary gland. Mutations in PIT1, PROP1 and LHX3 are associated with a posterior pituitary in the normal position in the sella turcica (Fofanova et al., 2000; Netchine et al., 2000; Parks et al., 1999). We screened 93 individuals with an ectopic/undescended posterior pituitary and found HESX1 mutations in only 5 individuals. The descent of the posterior pituitary may therefore be dependent upon a number of developmental genes that are expressed at an early stage of pituitary organogenesis. The association of an ectopic/undescended posterior pituitary with isolated GH deficiency suggests that somatotrope differentiation/proliferation and consequent GH secretion may be particularly vulnerable to dissociation between the anterior (derived from Rathkes pouch) and posterior (derived from neuroectoderm) lobes.
Based on our in vitro studies, we would predict that, in the absence of allelic exclusion, a patient who is heterozygous for HESX1(R160C) would have much less than 50% of active HESX1 protein. Based on dominant negative experiments with wild-type HESX1 we would predict that these patients may have as little as 10% of the normal concentrations of active wild-type HESX1 dimers. The implication of these findings is that there may be sufficient active protein to escape a phenotype in a statistically significant number of patients. These observations may be consistent with the variable penetrance of the Hesx1 targeted mutation in mice (Dattani et al., 1998). By analogy, it seems unlikely that patients heterozygous for HESX1(S170L) would display a phenotype, if the only consequence of this mutation was to reduce DNA binding of one allele by 5-fold (based on Kds determined for both dimer and monomer sites). The S170L substitution is located immediately C-terminal to the homeodomain in an RESQLF motif, which is completely conserved in, and unique to, HESX1 homeoproteins. Recent structural studies of Pbx1 class homeodomains highlight the importance of homeodomain-flanking residues/motifs and may provide insight into the functional role of the RESQLF motif (Piper et al., 1999). Pbx class homeodomains, which bind as heterodimers with Hox class proteins, also contain a conserved stretch of residues C-terminal to the homeodomain. In Pbx1 these residues fold into a fourth -helix that forms an integral part of the homeodomain-binding complex by making specific contacts with homeodomain residues. Replacement of the F298 residue within the Pbx homeodomain C-terminal tail (F298 is the homologous position to S170 in Hesx1) results in a reduction in both monomeric and cooperative DNA binding (Lu and Kamps, 1996). This analogy suggests that the S170L mutation is positioned such that it alters interactions between Hesx1 and its partners, suggesting a possible mode for dominant inheritance.
Modulation of the interactions between Hesx1 and partner proteins involved in normal forebrain and pituitary development may explain the variable penetrance and expressivity of the SOD phenotype (Arslanian et al., 1984). The expression patterns of members of the Mix family suggest that they may be true physiological partners of Hesx1 and thus candidates for additional mutations associated with the SOD phenotypic spectrum.
![]() |
ACKNOWLEDGMENTS |
---|
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Arslanian, S. A., Rothfus, W. E., Foley, T. P., Jr and Becker, D. J. (1984). Hormonal, metabolic, and neuroradiologic abnormalities associated with septo-optic dysplasia. Acta Endocrinol. 107, 282-288.[Medline]
Brickman, J. M., Adam, M. and Ptashne, M. (1999). Interactions between an HMG-1 protein and members of the rel family. Proc. Natl. Acad. Sci. USA 96, 10679-10683.
Brickman, J. M., Jones, C. M., Clements, M., Smith, J. C. and Beddington, R. S. P. (2000). Hex is a transcriptional repressor that contributes to anterior identity and suppresses Spemann organiser function. Development 127, 2303-2315.
Dattani, M. T., Martinez-Barbera, J. P., Thomas, P. Q., Brickman, J. M., Gupta, R., Martensson, I. L., Toresson, H., Fox, M., Wales, J. K., Hindmarsh, P. C. et al. (1998). Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse. Nat. Genet. 19, 125-133.[Medline]
Dattani, M. T., Martinez-Barbera, J. P., Thomas, P. Q., Brickman, J. M., Gupta, R., Wales, J. K., Hindmarsh, P. C., Beddington, R. S. and Robinson, I. C. (1999). HESX1: a novel gene implicated in a familial form of septo-optic dysplasia. Acta Paediatr. Suppl. 88, 49-54.
Desplan, C., Theis, J. and OFarrell, P. H. (1988). The sequence specificity of homeodomain-DNA interaction. Cell 54, 1081-1090.[Medline]
Dubnicoff, T., Valentine, S. A., Chen, G., Shi, T., Lengyel, J. A., Paroush, Z. and Courey, A. J. (1997). Conversion of dorsal from an activator to a repressor by the global corepressor Groucho. Genes Dev. 11, 2952-2957.
Duboule, D. (1994). Guidebook to the Homeobox Genes. Oxford, New York: Oxford University Press.
Emami, K. H. and Carey, M. (1992). A synergistic increase in potency of a multimerized VP16 transcriptional activation domain. EMBO J. 11, 5005-5012.[Abstract]
Fisher, J. P., Hope, S. A. and Hooper, M. L. (1989). Factors influencing the differentiation of embryonal carcinoma and embryo-derived stem cells. Exp. Cell Res. 182, 403-414.[Medline]
Fofanova, O., Takamura, N., Kinoshita, E., Vorontsov, A., Vladimirova, V., Dedov, I., Peterkova, V. and Yamashita, S. (2000). MR imaging of the pituitary gland in children and young adults with congenital combined pituitary hormone deficiency associated with PROP1 mutations. Am. J. Roentgenol. 174, 555-559.
Gehring, W. J., Affolter, M. and Burglin, T. (1994). Homeodomain proteins. Annu. Rev. Biochem. 63, 487-526.[Medline]
Germain, S., Howell, M., Esslemont, G. M. and Hill, C. S. (2000). Homeodomain and winged-helix transcription factors recruit activated Smads to distinct promoter elements via a common Smad interaction motif. Genes Dev. 14, 435-451.
Hanna-Rose, W. and Hansen, U. (1996). Active repression mechanisms of eukaryotic transcription repressors. Trends Genet. 12, 229-234.[Medline]
Henry, G. L. and Melton, D. A. (1998). Mixer, a homeobox gene required for endoderm development. Science 281, 91-96.
Hermesz, E., Mackem, S. and Mahon, K. A. (1996). Rpx: a novel anterior-restricted homeobox gene progressively activated in the prechordal plate, anterior neural plate and Rathkes pouch of the mouse embryo. Development 122, 41-52.
Jimenez, G., Paroush, Z. and Ish-Horowicz, D. (1997). Groucho acts as a corepressor for a subset of negative regulators, including Hairy and Engrailed. Genes Dev. 11, 3072-3082.
Jimenez, G., Verrijzer, C. P. and Ish-Horowicz, D. (1999). A conserved motif in goosecoid mediates groucho-dependent repression in Drosophila embryos. Mol. Cell Biol. 19, 2080-2087.
Latinkic, B. V. and Smith, J. C. (1999). Goosecoid and mix.1 repress Brachyury expression and are required for head formation in Xenopus. Development 126, 1769-1779.
Levine, M. and Manley, J. L. (1989). Transcriptional repression of eukaryotic promoters. Cell 59, 405-408.[Medline]
Lin, Y. S., Carey, M. F., Ptashne, M. and Green, M. R. (1988). GAL4 derivatives function alone and synergistically with mammalian activators in vitro. Cell 54, 659-664.[Medline]
Lu, Q. and Kamps, M. P. (1996). Structural determinants within Pbx1 that mediate cooperative DNA binding with pentapeptide containing Hox proteins: proposal for a model of a Pbx1-Hox-DNA complex. Mol. Cell Biol. 16, 1632-1640.[Abstract]
Mailhos, C., Andre, S., Mollereau, B., Goriely, A., Hemmati-Brivanlou, A. and Desplan, C. (1998). Drosophila Goosecoid requires a conserved heptapeptide for repression of paired-class homeoprotein activators. Development 125, 937-947.
McKnight, S. and Tjian, R. (1986). Transcriptional selectivity of viral genes in mammalian cells. Cell 46, 795-805.[Medline]
Mead, P. E., Brivanlou, I. H., Kelley, C. M. and Zon, L. I. (1996). BMP-4-responsive regulation of dorsal-ventral patterning by the homeobox protein Mix.1. Nature 382, 357-360.[Medline]
Mountford, P., Zevnik, B., Duwel, A., Nichols, J., Li, M., Dani, C., Robertson, M., Chambers, I. and Smith, A. (1994). Dicistronic targeting constructs: reporters and modifiers of mammalian gene expression. Proc. Natl. Acad. Sci. USA 91, 4303-4307.[Abstract]
Netchine, I., Sobrier, M. L., Krude, H., Schnabel, D., Maghnie, M., Marcos, E., Duriez, B., Cacheux, V., Moers, A., Goossens, M. et al. (2000). Mutations in LHX3 result in a new syndrome revealed by combined pituitary hormone deficiency. Nat. Genet. 25, 182-186.[Medline]
Parks, J. S., Brown, M. R., Hurley, D. L., Phelps, C. J. and Wajnrajch, M. P. (1999). Heritable disorders of pituitary development. J. Clin. Endocrinol. Metab. 84, 4362-4370.
Piper, D. E., Batchelor, A. H., Chang, C. P., Cleary, M. L. and Wolberger, C. (1999). Structure of a HoxB1-Pbx1 heterodimer bound to DNA: role of the hexapeptide and a fourth homeodomain helix in complex formation. Cell 96, 587-597.[Medline]
Schier, A. F. and Gehring, W. J. (1992). Direct homeodomain-DNA interaction in the autoregulation of the fushi tarazu gene. Nature 356, 804-807.[Medline]
Smith, A. G., Heath, J. K., Donaldson, D. D., Wong, G. G., Moreau, J., Stahl, M. and Rogers, D. (1988). Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature 336, 688-690.[Medline]
Smith, S. T. and Jaynes, J. B. (1996). A conserved region of engrailed, shared among all en-, gsc-, Nk1-, Nk2- and msh-class homeoproteins, mediates active transcriptional repression in vivo. Development 122, 3141-3150.
Sornson, M. W., Wu, W., Dasen, J. S., Flynn, S. E., Norman, D. J., OConnell, S. M., Gukovsky, I., Carriere, C., Ryan, A. K., Miller, A. P. et al. (1996). Pituitary lineage determination by the Prophet of Pit-1 homeodomain factor defective in Ames dwarfism. Nature 384, 327-333.[Medline]
Tada, M., Casey, E. S., Fairclough, L. and Smith, J. C. (1998). Bix1, a direct target of Xenopus T-box genes, causes formation of ventral mesoderm and endoderm. Development 125, 3997-4006.
Thomas, P. and Beddington, R. (1996). Anterior primitive endoderm may be responsible for patterning the anterior neural plate in the mouse embryo. Curr. Biol. 6, 1487-1496.[Medline]
Thomas, P. Q., Dattani, M. T., Brickman, J. M., McNay, D., Warne, G., Zacharin, M., Cameron, F., Hurst, J., Woods, K., Dunger, D. et al. (2001). Heterozygous HESX1 mutations associated with isolated congenital pituitary hypoplasia and septo-optic dysplasia. Hum. Mol. Genet. 10, 39-45.
Tolkunova, E. N., Fujioka, M., Kobayashi, M., Deka, D. and Jaynes, J. B. (1998). Two distinct types of repression domain in engrailed: one interacts with the groucho corepressor and is preferentially active on integrated target genes. Mol. Cell Biol. 18, 2804-2814.
Treisman, J., Gonczy, P., Vashishtha, M., Harris, E. and Desplan, C. (1989). A single amino acid can determine the DNA binding specificity of homeodomain proteins. Cell 59, 553-562.[Medline]
Valentine, S. A., Chen, G., Shandala, T., Fernandez, J., Mische, S., Saint, R. and Courey, A. J. (1998). Dorsal-mediated repression requires the formation of a multiprotein repression complex at the ventral silencer. Mol. Cell Biol. 18, 6584-6594.
Wales, J. K. and Quarrell, O. W. (1996). Evidence for possible Mendelian inheritance of septo-optic dysplasia. Acta Paediatr. 85, 391-392.[Medline]
Wilson, D., Sheng, G., Lecuit, T., Dostatni, N. and Desplan, C. (1993). Cooperative dimerization of paired class homeo domains on DNA. Genes Dev. 7, 2120-2134.[Abstract]
Winnier, A. R., Meir, J. Y., Ross, J. M., Tavernarakis, N., Driscoll, M., Ishihara, T., Katsura, I. and Miller, D. M., 3rd (1999). UNC-4/UNC-37-dependent repression of motor neuron-specific genes controls synaptic choice in Caenorhabditis elegans. Genes Dev. 13, 2774-2786.
Wolberger, C. (1996). Homeodomain interactions. Curr. Opin. Struct. Biol. 6, 62-68.[Medline]
Xu, L., Lavinsky, R. M., Dasen, J. S., Flynn, S. E., McInerney, E. M., Mullen, T. M., Heinzel, T., Szeto, D., Korzus, E., Kurokawa, R. et al. (1998). Signal-specific co-activator domain requirements for Pit-1 activation. Nature 395, 301-306.[Medline]